Dr. Matthew Ian Gembala, MD, MPH
- Medicare services, 2024
- 932
- Medicare patients, 2024
- 441
- Part D claims, 2024
- 1,158
- MIPS score, 2024
- 88
- Hospital affiliations
- 5
- Practice address
- 3890 Park Central N Blvd, Pompano Beach, FL 33064
- Practice phone
- Call (928) 556-5500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
U.S. Renal Care Flagstaff Dialysis
Pompano Beach, Florida
Find Dr. Gembala's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew Ian Gembala is a nephrologist in Pompano Beach, Florida
Dr. Gembala practices at U.S. Renal Care Flagstaff Dialysis in Pompano Beach, Florida.
Dr. Gembala's NPI, 1114950185, was assigned on July 10, 2006. Dr. Gembala graduated from University of Arizona College of Medicine in 2003. Dr. Gembala holds Arizona license 35737.
- NPI
- 1114950185NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5890888002
- NPI enumeration date
- July 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (928) 556-5500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Matthew Ian Gembala practices at U.S. Renal Care Flagstaff Dialysis in Pompano Beach, Florida
Dr. Gembala's primary practice is U.S. Renal Care Flagstaff Dialysis, at 3890 Park Central N Blvd, Pompano Beach, FL 33064 in Broward County. The practice phone is (928) 556-5500.
- U.S. Renal Care Flagstaff Dialysis3890 Park Central N Blvd, Pompano Beach, FL 33064 · Broward CountyPhone(928) 556-5500
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Matthew Ian Gembala is affiliated with 10 sites of care and 1 medical group
Dr. Gembala's primary practice is U.S. Renal Care Flagstaff Dialysis in Pompano Beach, Florida. Dr. Gembala is also affiliated with Flagstaff Medical Center. The medical group on file is Arizona Kidney Disease & Hypertension Centers (AKDHC). Dmand AI also links Dr. Gembala to 4 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Matthew Ian Gembala's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gembala practices, 9 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| U.S. Renal Care Flagstaff Dialysis | Available with a free account |
| +9 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew Ian Gembala is one of 917 nephrologists in Florida
Nephrology is Dr. Gembala's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Gembala is licensed in Arizona.
Specialties and state licenses
- Nephrology, ArizonaPrimary
Nephrologists near Dr. Gembala
Counts of nephrologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew Ian Gembala billed Medicare for 932 services in 2024
CMS data shows 932 Medicare services from Dr. Gembala across 9 procedure codes in 2024, for 441 Medicare patients. Medicare paid $113,349 for them.
Dr. Gembala's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 6732024: 85026%
- Tests and treatments
- 2023: 3432024: 5584%
- Other services
- 2023: 02024: 27
Where Dr. Gembala's Medicare services took place, 2024
- In an office83890%
- In a facility9410%
Dr. Gembala compared with the Florida median for nephrologists, 2024
- Dr. Gembala
- Florida median
- Medicare services
- 932vs 1,49037% below
- Medicare patients
- 441vs 38714% above
- Part D claims
- 885vs 9345% below
Medians across 882 nephrologists in Florida with Dmand AI profiles that report each measure.
Dr. Gembala's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gembala?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gembala and other nephrologists in Florida.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Matthew Ian Gembala treated 441 Medicare patients in 2024, average age 74
CMS counts 441 Medicare patients who saw Dr. Gembala in 2024. The largest group is 65 to 74, with 190 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Gembala's median patient age at 73, with 50% women.
Dr. Gembala's Medicare patients by age, 2024
Dr. Gembala's Medicare patients by sex, 2024
- Women21749%
- Men22451%
Chronic conditions among Dr. Gembala's Medicare patients, 2024
- Chronic kidney disease75%
- High blood pressure75%
- High cholesterol75%
- Arthritis48%
- Diabetes45%
- Ischemic heart disease36%
- Atrial fibrillation26%
- Heart failure23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Gembala's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 73
Patient panel by sex, all payers
- Women50%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Matthew Ian Gembala wrote 1,158 Medicare Part D claims in 2024
In 2024, Dr. Gembala wrote 1,158 Medicare Part D claims for 213 patients. 89% of them were for generic drugs. CMS names the drug for 885 of them, across 28 drugs with 11 or more claims each, at $202,903 in total drug cost. In 2023, CMS named 727 claims across 23 drugs.
Dr. Gembala's Part D claims by kind of drug, 2024
- Generic1,026 claims89%
- Brand-name132 claims11%
Dr. Gembala's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Gembala's Part D claims, 2024
- Antibiotics2%20 of 1,158 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7272024: 88522%
Drugs named by CMS: 28 in 2024, 23 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Matthew Ian Gembala scored 88 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Gembala for performance year 2024, reported as part of a group. Dr. Gembala accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Gembala's MIPS scores, performance year 2024
- 88of 100Final score
- 67.7of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew Ian Gembala received $5,212 in industry payments from 2016 to 2025
CMS Open Payments shows 183 general payments to Dr. Gembala from 32 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $940.
General payments to Dr. Gembala by program year, 2016 to 2025
General payments to Dr. Gembala by kind, 2016 to 2025
- Food and beverage$5,05797%
- Education$1292%
- Travel and lodging$250%
Companies that paid Dr. Gembala the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Matthew Ian Gembala graduated from University of Arizona College of Medicine
Dr. Gembala graduated from University of Arizona College of Medicine in 2003.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Matthew Ian Gembala's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew Ian Gembala
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew Ian Gembala's NPI number?
Dr. Matthew Ian Gembala's NPI number is 1114950185. It was assigned on July 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew Ian Gembala?
Dr. Matthew Ian Gembala is a nephrologist in Pompano Beach, Florida. The primary specialty in the NPI Registry is Nephrology Physician (taxonomy code 207RN0300X).
Where does Dr. Matthew Ian Gembala practice?
Dr. Gembala practices at 3890 Park Central N Blvd, Pompano Beach, FL 33064. Dr. Gembala's primary practice is U.S. Renal Care Flagstaff Dialysis in Pompano Beach, Florida. Dmand AI also links Dr. Gembala to 4 hospitals, 3 dialysis centers and 1 group practice or clinic.
What is Dr. Matthew Ian Gembala's office phone number?
The practice phone on file for Dr. Gembala is (928) 556-5500.
What is Dr. Matthew Ian Gembala's medical license number?
Dr. Gembala holds Arizona license 35737.
Which hospitals is Dr. Matthew Ian Gembala affiliated with?
Dr. Gembala is affiliated with Flagstaff Medical Center. Dmand AI links Dr. Gembala to 4 more hospitals.
What medical group is Dr. Matthew Ian Gembala part of?
Dr. Gembala is linked to Arizona Kidney Disease & Hypertension Centers (AKDHC).
Does Dr. Matthew Ian Gembala accept Medicare?
Yes. CMS data shows Dr. Gembala billed Medicare for 932 services in 2024, and Dr. Gembala accepts Medicare assignment.
What is Dr. Matthew Ian Gembala's MIPS score?
Dr. Gembala's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.
How many Medicare patients does Dr. Matthew Ian Gembala see?
CMS counts 441 Medicare patients who saw Dr. Gembala in 2024, with an average age of 74.
Show 5 more questionsShow fewer questions
What services does Dr. Matthew Ian Gembala bill to Medicare?
In 2024, Dr. Gembala's most billed Medicare services were office visit, established patient (99215), office visit, new patient (99205) and hospital inpatient care (99233).
Where did Dr. Matthew Ian Gembala go to medical school?
Dr. Gembala graduated from University of Arizona College of Medicine in 2003.
What drugs does Dr. Matthew Ian Gembala prescribe most?
In 2024 Medicare Part D data, Dr. Gembala's most prescribed drugs by claims were Losartan Potassium, Allopurinol and Amlodipine Besylate.
Has Dr. Matthew Ian Gembala received payments from drug or device companies?
CMS Open Payments shows $5,212 in general payments to Dr. Gembala from 32 companies from 2016 to 2025. The largest total came from Otsuka America Pharmaceutical, Inc.
How long has Dr. Matthew Ian Gembala been practicing?
Dr. Gembala graduated from medical school in 2003, 23 years ago.
Selling to nephrology practices?
See nephrologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card